June 05, 2023 22:34 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Guard missing after Rs 1,700 crore under-construction bridge collapses in Bihar | 'This is our fight for justice...we will not step back': Top wrestlers rejoin work | PM Modi to address joint session of US Congress on June 22 | Goa-Mumbai Vande Bharat Express launch ceremony cancelled after Odisha train mishap | At least 50 killed, 300 injured in Coromandel Express mishap in Odisha's Balasore, massive rescue ops underway
MSN Group launches urinary incontinence drug MSN Labs
MSN Groups Facebook page

MSN Group launches urinary incontinence drug

India Blooms News Service | @indiablooms | 22 Mar 2023, 06:32 pm

Kolkata: MSN Labs, a research-based and fully-integrated global pharmaceutical company based out of Hyderabad, announced the launch of Fesobig, a bio-equivalent generic version of Fesoterodine Fumarate.

The company said Fesobig has been recommended as the safest, novel first line pharmacotherapy option by various international treatment guidelines for the treatment of overactive bladder (OAB) and Uninary Incontinence (UI).

“The launch of Fesobig (Fesoterodine) tablets is in line with our ongoing commitment to research in bringing affordable medications across critical therapies for alleviating the suffering of the Indian patients.” M.S.N. Reddy, Chairman & Managing Director, MSN Group commented.

Speaking on occasion, Bharat Reddy, Executive Director, MSN Group, said, “Besides helping recover from overactive bladder (OAB), we are certain that Fesobig will endow patients with a much confident way of life by eliminating the social and psychological discomfort associated with the condition. We have ensured that drug is priced affordably so that it can benefit a vast majority of patients.”

The guest speaker Dr K Lalitha, consultant urologist, spoke on the prevalence of OAB in India. According to the studies,1 in 3 women above the age of 50 suffers from urinary incontinence impacting their quality of life.

Anuradha Koduri, HOD - Gynecology, KIMS Hospital, spoke on the social stigma associated with the condition and stated that a majority of patients shy away from treatment due to the lack of awareness and accept it as a part of ageing process.This, in the long run,leads to various medical complications.

A V Ravikumar, consultant urologist further elucidated on the various medical avenues including behavioral therapy, drugs and surgical options available in treating OAB.